nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—GSTM1—Azathioprine—systemic scleroderma	0.298	0.44	CbGbCtD
Cisplatin—XDH—Azathioprine—systemic scleroderma	0.124	0.183	CbGbCtD
Cisplatin—ABCG2—Leflunomide—systemic scleroderma	0.0516	0.0762	CbGbCtD
Cisplatin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0353	0.052	CbGbCtD
Cisplatin—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0319	0.0471	CbGbCtD
Cisplatin—ABCC3—Methotrexate—systemic scleroderma	0.0311	0.0459	CbGbCtD
Cisplatin—ABCB1—Lisinopril—systemic scleroderma	0.0195	0.0288	CbGbCtD
Cisplatin—CYP2C9—Leflunomide—systemic scleroderma	0.0192	0.0283	CbGbCtD
Cisplatin—ABCB1—Captopril—systemic scleroderma	0.0146	0.0216	CbGbCtD
Cisplatin—ABCC2—Methotrexate—systemic scleroderma	0.0141	0.0209	CbGbCtD
Cisplatin—ABCG2—Methotrexate—systemic scleroderma	0.0128	0.0189	CbGbCtD
Cisplatin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0115	0.017	CbGbCtD
Cisplatin—ABCC6—dermis—systemic scleroderma	0.0105	0.104	CbGeAlD
Cisplatin—ABCB1—Prednisone—systemic scleroderma	0.00919	0.0136	CbGbCtD
Cisplatin—CYP2C9—cardial valve—systemic scleroderma	0.0077	0.0763	CbGeAlD
Cisplatin—ABCB1—Methotrexate—systemic scleroderma	0.00461	0.00681	CbGbCtD
Cisplatin—ATP7A—endothelium—systemic scleroderma	0.0035	0.0347	CbGeAlD
Cisplatin—GSTM1—artery—systemic scleroderma	0.00345	0.0342	CbGeAlD
Cisplatin—ATP7A—blood vessel—systemic scleroderma	0.00323	0.032	CbGeAlD
Cisplatin—GSTM1—blood vessel—systemic scleroderma	0.00269	0.0266	CbGeAlD
Cisplatin—PTGS2—skeletal joint—systemic scleroderma	0.00241	0.0239	CbGeAlD
Cisplatin—MT1A—connective tissue—systemic scleroderma	0.0023	0.0227	CbGeAlD
Cisplatin—MPO—artery—systemic scleroderma	0.00222	0.022	CbGeAlD
Cisplatin—MT2A—connective tissue—systemic scleroderma	0.00191	0.0189	CbGeAlD
Cisplatin—MPO—endothelium—systemic scleroderma	0.00188	0.0186	CbGeAlD
Cisplatin—MPO—blood vessel—systemic scleroderma	0.00173	0.0172	CbGeAlD
Cisplatin—MT2A—skin of body—systemic scleroderma	0.00173	0.0171	CbGeAlD
Cisplatin—MT1A—digestive system—systemic scleroderma	0.00166	0.0164	CbGeAlD
Cisplatin—ATP7A—connective tissue—systemic scleroderma	0.00166	0.0164	CbGeAlD
Cisplatin—CYP4A11—digestive system—systemic scleroderma	0.00153	0.0151	CbGeAlD
Cisplatin—ABCC6—connective tissue—systemic scleroderma	0.00152	0.0151	CbGeAlD
Cisplatin—MT1A—lung—systemic scleroderma	0.00138	0.0137	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00138	0.624	CbGdCrCtD
Cisplatin—MT2A—digestive system—systemic scleroderma	0.00138	0.0137	CbGeAlD
Cisplatin—GSTM1—connective tissue—systemic scleroderma	0.00138	0.0137	CbGeAlD
Cisplatin—GSTT1—digestive system—systemic scleroderma	0.00135	0.0134	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—systemic scleroderma	0.00133	0.0131	CbGeAlD
Cisplatin—SLC31A2—tendon—systemic scleroderma	0.00129	0.0128	CbGeAlD
Cisplatin—GSTM1—skin of body—systemic scleroderma	0.00124	0.0123	CbGeAlD
Cisplatin—ATP7B—lung—systemic scleroderma	0.00124	0.0123	CbGeAlD
Cisplatin—MT2A—lung—systemic scleroderma	0.00115	0.0114	CbGeAlD
Cisplatin—ATP7A—tendon—systemic scleroderma	0.00114	0.0113	CbGeAlD
Cisplatin—SLC31A2—lung—systemic scleroderma	0.00113	0.0112	CbGeAlD
Cisplatin—GSTT1—lung—systemic scleroderma	0.00113	0.0112	CbGeAlD
Cisplatin—SLC31A1—digestive system—systemic scleroderma	0.00102	0.0101	CbGeAlD
Cisplatin—PTGS2—artery—systemic scleroderma	0.00101	0.00999	CbGeAlD
Cisplatin—XDH—digestive system—systemic scleroderma	0.00101	0.00998	CbGeAlD
Cisplatin—ATP7A—lung—systemic scleroderma	0.000999	0.0099	CbGeAlD
Cisplatin—SOD1—tendon—systemic scleroderma	0.000996	0.00987	CbGeAlD
Cisplatin—GSTM1—digestive system—systemic scleroderma	0.000996	0.00986	CbGeAlD
Cisplatin—SLC31A1—tendon—systemic scleroderma	0.000971	0.00962	CbGeAlD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—GDF15—systemic scleroderma	0.000967	0.0356	CbGpPWpGaD
Cisplatin—NQO1—connective tissue—systemic scleroderma	0.000966	0.00957	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.000939	0.0346	CbGpPWpGaD
Cisplatin—ABCC6—lung—systemic scleroderma	0.000916	0.00908	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—IRF5—systemic scleroderma	0.000902	0.0332	CbGpPWpGaD
Cisplatin—MPO—connective tissue—systemic scleroderma	0.000888	0.0088	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—systemic scleroderma	0.000884	0.00876	CbGeAlD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SMAD7—systemic scleroderma	0.000875	0.0322	CbGpPWpGaD
Cisplatin—SOD1—lung—systemic scleroderma	0.000874	0.00866	CbGeAlD
Cisplatin—NQO1—skin of body—systemic scleroderma	0.000872	0.00864	CbGeAlD
Cisplatin—GSTP1—connective tissue—systemic scleroderma	0.000863	0.00855	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—IRF8—systemic scleroderma	0.000862	0.0317	CbGpPWpGaD
Cisplatin—XDH—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.000857	0.0316	CbGpPWpGaD
Cisplatin—SLC31A1—lung—systemic scleroderma	0.000852	0.00844	CbGeAlD
Cisplatin—PTGS2—endothelium—systemic scleroderma	0.000852	0.00844	CbGeAlD
Cisplatin—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000835	0.376	CbGdCrCtD
Cisplatin—GSTM1—lung—systemic scleroderma	0.000832	0.00824	CbGeAlD
Cisplatin—MPO—skin of body—systemic scleroderma	0.000802	0.00795	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—systemic scleroderma	0.00079	0.00783	CbGeAlD
Cisplatin—SLC22A2—digestive system—systemic scleroderma	0.00079	0.00782	CbGeAlD
Cisplatin—PTGS2—blood vessel—systemic scleroderma	0.000786	0.00778	CbGeAlD
Cisplatin—GSTP1—skin of body—systemic scleroderma	0.00078	0.00772	CbGeAlD
Cisplatin—ABCC5—tendon—systemic scleroderma	0.00071	0.00703	CbGeAlD
Cisplatin—MPO—IL23-mediated signaling events—STAT4—systemic scleroderma	0.000698	0.0257	CbGpPWpGaD
Cisplatin—NQO1—digestive system—systemic scleroderma	0.000698	0.00691	CbGeAlD
Cisplatin—SOD1—Folate Metabolism—CSF1—systemic scleroderma	0.00069	0.0254	CbGpPWpGaD
Cisplatin—NQO1—tendon—systemic scleroderma	0.000664	0.00658	CbGeAlD
Cisplatin—MPO—digestive system—systemic scleroderma	0.000642	0.00636	CbGeAlD
Cisplatin—ABCC3—digestive system—systemic scleroderma	0.000626	0.0062	CbGeAlD
Cisplatin—GSTP1—digestive system—systemic scleroderma	0.000624	0.00618	CbGeAlD
Cisplatin—ABCC5—lung—systemic scleroderma	0.000623	0.00617	CbGeAlD
Cisplatin—SOD1—Platelet degranulation—SELP—systemic scleroderma	0.000614	0.0226	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—CSF1—systemic scleroderma	0.000602	0.0222	CbGpPWpGaD
Cisplatin—GSTP1—tendon—systemic scleroderma	0.000594	0.00588	CbGeAlD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.000584	0.0215	CbGpPWpGaD
Cisplatin—NQO1—lung—systemic scleroderma	0.000583	0.00577	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DQB1—systemic scleroderma	0.000538	0.0198	CbGpPWpGaD
Cisplatin—MPO—lung—systemic scleroderma	0.000536	0.00531	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000533	0.0196	CbGpPWpGaD
Cisplatin—ABCC3—lung—systemic scleroderma	0.000523	0.00518	CbGeAlD
Cisplatin—GSTP1—lung—systemic scleroderma	0.000521	0.00516	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000508	0.0187	CbGpPWpGaD
Cisplatin—ABCC2—digestive system—systemic scleroderma	0.0005	0.00496	CbGeAlD
Cisplatin—ABCB1—blood vessel—systemic scleroderma	0.000486	0.00481	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—systemic scleroderma	0.000478	0.00474	CbGeAlD
Cisplatin—ABCC2—tendon—systemic scleroderma	0.000476	0.00472	CbGeAlD
Cisplatin—BCHE—skin of body—systemic scleroderma	0.000472	0.00468	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000453	0.0167	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—IRF5—systemic scleroderma	0.000441	0.0162	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000427	0.0157	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—IRF8—systemic scleroderma	0.000421	0.0155	CbGpPWpGaD
Cisplatin—CYP2B6—skin of body—systemic scleroderma	0.000421	0.00417	CbGeAlD
Cisplatin—PTGS2—connective tissue—systemic scleroderma	0.000403	0.00399	CbGeAlD
Cisplatin—BCHE—digestive system—systemic scleroderma	0.000378	0.00374	CbGeAlD
Cisplatin—PTGS2—smooth muscle tissue—systemic scleroderma	0.000368	0.00365	CbGeAlD
Cisplatin—PTGS2—skin of body—systemic scleroderma	0.000364	0.0036	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000347	0.0128	CbGpPWpGaD
Cisplatin—CYP2B6—digestive system—systemic scleroderma	0.000337	0.00334	CbGeAlD
Cisplatin—CYP2C9—digestive system—systemic scleroderma	0.000333	0.0033	CbGeAlD
Cisplatin—MPO—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000323	0.0119	CbGpPWpGaD
Cisplatin—BCHE—lung—systemic scleroderma	0.000315	0.00312	CbGeAlD
Cisplatin—ABCG2—lung—systemic scleroderma	0.000305	0.00302	CbGeAlD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000294	0.0108	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.000293	0.0108	CbGpPWpGaD
Cisplatin—PTGS2—digestive system—systemic scleroderma	0.000291	0.00288	CbGeAlD
Cisplatin—ABCC5—Defective B3GAT3 causes JDSSDHD—HSPG2—systemic scleroderma	0.000287	0.0106	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000287	0.0106	CbGpPWpGaD
Cisplatin—CYP2B6—lung—systemic scleroderma	0.000281	0.00279	CbGeAlD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.000281	0.0104	CbGpPWpGaD
Cisplatin—PTGS2—tendon—systemic scleroderma	0.000277	0.00274	CbGeAlD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000272	0.01	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DQB1—systemic scleroderma	0.000263	0.00968	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000254	0.00935	CbGpPWpGaD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000252	0.0093	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00025	0.00921	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000248	0.00915	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000245	0.00903	CbGpPWpGaD
Cisplatin—PTGS2—lung—systemic scleroderma	0.000243	0.00241	CbGeAlD
Cisplatin—SOD1—Folate Metabolism—CCL2—systemic scleroderma	0.000233	0.00859	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000231	0.00852	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000222	0.00817	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000217	0.008	CbGpPWpGaD
Cisplatin—Asthenia—Mometasone—systemic scleroderma	0.000208	0.00109	CcSEcCtD
Cisplatin—Irritability—Prednisone—systemic scleroderma	0.000208	0.00109	CcSEcCtD
Cisplatin—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00109	CcSEcCtD
Cisplatin—Hypotension—Azathioprine—systemic scleroderma	0.000208	0.00108	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000208	0.00108	CcSEcCtD
Cisplatin—Polyuria—Methotrexate—systemic scleroderma	0.000208	0.00108	CcSEcCtD
Cisplatin—SOD1—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000208	0.00765	CbGpPWpGaD
Cisplatin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00108	CcSEcCtD
Cisplatin—Tremor—Lisinopril—systemic scleroderma	0.000207	0.00108	CcSEcCtD
Cisplatin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000207	0.00108	CcSEcCtD
Cisplatin—Discomfort—Mycophenolic acid—systemic scleroderma	0.000207	0.00108	CcSEcCtD
Cisplatin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000206	0.00107	CcSEcCtD
Cisplatin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000206	0.00107	CcSEcCtD
Cisplatin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000205	0.00107	CcSEcCtD
Cisplatin—Tachycardia—Leflunomide—systemic scleroderma	0.000205	0.00107	CcSEcCtD
Cisplatin—MT2A—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000205	0.00754	CbGpPWpGaD
Cisplatin—Anaemia—Lisinopril—systemic scleroderma	0.000205	0.00107	CcSEcCtD
Cisplatin—Skin disorder—Leflunomide—systemic scleroderma	0.000204	0.00106	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—CCL2—systemic scleroderma	0.000203	0.00749	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000203	0.00106	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000203	0.00106	CcSEcCtD
Cisplatin—Body temperature increased—Captopril—systemic scleroderma	0.000202	0.00105	CcSEcCtD
Cisplatin—CYP4A11—PPARA activates gene expression—CTGF—systemic scleroderma	0.000201	0.00741	CbGpPWpGaD
Cisplatin—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00105	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000201	0.00739	CbGpPWpGaD
Cisplatin—Oedema—Mycophenolic acid—systemic scleroderma	0.000201	0.00105	CcSEcCtD
Cisplatin—Anorexia—Leflunomide—systemic scleroderma	0.0002	0.00104	CcSEcCtD
Cisplatin—Nausea—Pentoxifylline—systemic scleroderma	0.0002	0.00104	CcSEcCtD
Cisplatin—Malaise—Lisinopril—systemic scleroderma	0.0002	0.00104	CcSEcCtD
Cisplatin—Infection—Mycophenolic acid—systemic scleroderma	0.000199	0.00104	CcSEcCtD
Cisplatin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00104	CcSEcCtD
Cisplatin—Diarrhoea—Mometasone—systemic scleroderma	0.000199	0.00104	CcSEcCtD
Cisplatin—Hypokalaemia—Prednisone—systemic scleroderma	0.000199	0.00104	CcSEcCtD
Cisplatin—Leukopenia—Lisinopril—systemic scleroderma	0.000198	0.00103	CcSEcCtD
Cisplatin—Renal failure acute—Methotrexate—systemic scleroderma	0.000198	0.00103	CcSEcCtD
Cisplatin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000197	0.00103	CcSEcCtD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000197	0.00725	CbGpPWpGaD
Cisplatin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000197	0.00103	CcSEcCtD
Cisplatin—Hypotension—Leflunomide—systemic scleroderma	0.000197	0.00102	CcSEcCtD
Cisplatin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000196	0.00102	CcSEcCtD
Cisplatin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000196	0.00102	CcSEcCtD
Cisplatin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000195	0.00102	CcSEcCtD
Cisplatin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000194	0.00101	CcSEcCtD
Cisplatin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000194	0.00101	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000192	0.001	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000192	0.000999	CcSEcCtD
Cisplatin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000191	0.000997	CcSEcCtD
Cisplatin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000996	CcSEcCtD
Cisplatin—MPO—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00019	0.00698	CbGpPWpGaD
Cisplatin—Paraesthesia—Leflunomide—systemic scleroderma	0.000189	0.000984	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000189	0.000983	CcSEcCtD
Cisplatin—Myalgia—Lisinopril—systemic scleroderma	0.000189	0.000982	CcSEcCtD
Cisplatin—Anxiety—Lisinopril—systemic scleroderma	0.000188	0.000979	CcSEcCtD
Cisplatin—Dyspnoea—Leflunomide—systemic scleroderma	0.000187	0.000977	CcSEcCtD
Cisplatin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000187	0.000977	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000187	0.000976	CcSEcCtD
Cisplatin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000972	CcSEcCtD
Cisplatin—Discomfort—Lisinopril—systemic scleroderma	0.000186	0.000971	CcSEcCtD
Cisplatin—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000186	0.000971	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—IL1A—systemic scleroderma	0.000186	0.00684	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000185	0.00682	CbGpPWpGaD
Cisplatin—Pancreatitis—Prednisone—systemic scleroderma	0.000185	0.000964	CcSEcCtD
Cisplatin—Vomiting—Mometasone—systemic scleroderma	0.000185	0.000963	CcSEcCtD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.000185	0.00679	CbGpPWpGaD
Cisplatin—Sweating increased—Prednisone—systemic scleroderma	0.000184	0.000958	CcSEcCtD
Cisplatin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000184	0.000956	CcSEcCtD
Cisplatin—Rash—Mometasone—systemic scleroderma	0.000183	0.000955	CcSEcCtD
Cisplatin—Asthenia—Captopril—systemic scleroderma	0.000183	0.000954	CcSEcCtD
Cisplatin—Dermatitis—Mometasone—systemic scleroderma	0.000183	0.000954	CcSEcCtD
Cisplatin—Decreased appetite—Leflunomide—systemic scleroderma	0.000183	0.000953	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000183	0.000953	CcSEcCtD
Cisplatin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000947	CcSEcCtD
Cisplatin—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000182	0.00669	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000182	0.000946	CcSEcCtD
Cisplatin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000181	0.000942	CcSEcCtD
Cisplatin—Oedema—Lisinopril—systemic scleroderma	0.000181	0.000942	CcSEcCtD
Cisplatin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00018	0.000939	CcSEcCtD
Cisplatin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000938	CcSEcCtD
Cisplatin—ABCB1—digestive system—systemic scleroderma	0.00018	0.00178	CbGeAlD
Cisplatin—Pain—Leflunomide—systemic scleroderma	0.00018	0.000937	CcSEcCtD
Cisplatin—Infection—Lisinopril—systemic scleroderma	0.00018	0.000936	CcSEcCtD
Cisplatin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000935	CcSEcCtD
Cisplatin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000179	0.000932	CcSEcCtD
Cisplatin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000177	0.000922	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—IL1B—systemic scleroderma	0.000177	0.00651	CbGpPWpGaD
Cisplatin—Tachycardia—Lisinopril—systemic scleroderma	0.000176	0.000919	CcSEcCtD
Cisplatin—Body temperature increased—Azathioprine—systemic scleroderma	0.000176	0.000918	CcSEcCtD
Cisplatin—Skin disorder—Lisinopril—systemic scleroderma	0.000176	0.000915	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000175	0.00646	CbGpPWpGaD
Cisplatin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000912	CcSEcCtD
Cisplatin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000175	0.00091	CcSEcCtD
Cisplatin—Diarrhoea—Captopril—systemic scleroderma	0.000175	0.00091	CcSEcCtD
Cisplatin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000174	0.000909	CcSEcCtD
Cisplatin—Irritability—Methotrexate—systemic scleroderma	0.000174	0.000908	CcSEcCtD
Cisplatin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000905	CcSEcCtD
Cisplatin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000173	0.000903	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000173	0.000903	CcSEcCtD
Cisplatin—Nausea—Mometasone—systemic scleroderma	0.000173	0.000899	CcSEcCtD
Cisplatin—Anorexia—Lisinopril—systemic scleroderma	0.000172	0.000898	CcSEcCtD
Cisplatin—Pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000894	CcSEcCtD
Cisplatin—Hypotension—Lisinopril—systemic scleroderma	0.000169	0.00088	CcSEcCtD
Cisplatin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000876	CcSEcCtD
Cisplatin—SOD1—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000167	0.00614	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000167	0.00614	CbGpPWpGaD
Cisplatin—Body temperature increased—Leflunomide—systemic scleroderma	0.000166	0.000866	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000166	0.000865	CcSEcCtD
Cisplatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000165	0.000862	CcSEcCtD
Cisplatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000861	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—systemic scleroderma	0.000165	0.00086	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000165	0.00086	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—systemic scleroderma	0.000165	0.00086	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000165	0.000858	CcSEcCtD
Cisplatin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000858	CcSEcCtD
Cisplatin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000164	0.000855	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000855	CcSEcCtD
Cisplatin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00085	CcSEcCtD
Cisplatin—Paraesthesia—Lisinopril—systemic scleroderma	0.000162	0.000846	CcSEcCtD
Cisplatin—Vomiting—Captopril—systemic scleroderma	0.000162	0.000846	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000162	0.00595	CbGpPWpGaD
Cisplatin—Dyspnoea—Lisinopril—systemic scleroderma	0.000161	0.00084	CcSEcCtD
Cisplatin—Rash—Captopril—systemic scleroderma	0.000161	0.000839	CcSEcCtD
Cisplatin—Dermatitis—Captopril—systemic scleroderma	0.000161	0.000838	CcSEcCtD
Cisplatin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000159	0.000827	CcSEcCtD
Cisplatin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000825	CcSEcCtD
Cisplatin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000825	CcSEcCtD
Cisplatin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00082	CcSEcCtD
Cisplatin—Decreased appetite—Lisinopril—systemic scleroderma	0.000157	0.000819	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000156	0.000813	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000156	0.00574	CbGpPWpGaD
Cisplatin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000809	CcSEcCtD
Cisplatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000808	CcSEcCtD
Cisplatin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000155	0.000808	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—systemic scleroderma	0.000155	0.000806	CcSEcCtD
Cisplatin—Pain—Lisinopril—systemic scleroderma	0.000155	0.000805	CcSEcCtD
Cisplatin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000805	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—IL1B—systemic scleroderma	0.000154	0.00568	CbGpPWpGaD
Cisplatin—ABCC5—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.000154	0.00568	CbGpPWpGaD
Cisplatin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000802	CcSEcCtD
Cisplatin—Bradycardia—Prednisone—systemic scleroderma	0.000154	0.000802	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000153	0.00565	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000798	CcSEcCtD
Cisplatin—Diarrhoea—Azathioprine—systemic scleroderma	0.000152	0.000794	CcSEcCtD
Cisplatin—Nausea—Captopril—systemic scleroderma	0.000152	0.00079	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000151	0.000788	CcSEcCtD
Cisplatin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000787	CcSEcCtD
Cisplatin—Asthenia—Leflunomide—systemic scleroderma	0.000151	0.000786	CcSEcCtD
Cisplatin—ABCB1—lung—systemic scleroderma	0.00015	0.00149	CbGeAlD
Cisplatin—BCHE—Peptide hormone metabolism—ACE—systemic scleroderma	0.00015	0.00553	CbGpPWpGaD
Cisplatin—Pancytopenia—Methotrexate—systemic scleroderma	0.00015	0.000781	CcSEcCtD
Cisplatin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000149	0.000776	CcSEcCtD
Cisplatin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000148	0.000774	CcSEcCtD
Cisplatin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000771	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000147	0.00542	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000752	CcSEcCtD
Cisplatin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000144	0.00075	CcSEcCtD
Cisplatin—Diarrhoea—Leflunomide—systemic scleroderma	0.000144	0.00075	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000143	0.00526	CbGpPWpGaD
Cisplatin—Body temperature increased—Lisinopril—systemic scleroderma	0.000143	0.000745	CcSEcCtD
Cisplatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000741	CcSEcCtD
Cisplatin—Vomiting—Azathioprine—systemic scleroderma	0.000142	0.000738	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000141	0.0052	CbGpPWpGaD
Cisplatin—Eye disorder—Prednisone—systemic scleroderma	0.000141	0.000736	CcSEcCtD
Cisplatin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000736	CcSEcCtD
Cisplatin—SOD1—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.00014	0.00517	CbGpPWpGaD
Cisplatin—Rash—Azathioprine—systemic scleroderma	0.00014	0.000732	CcSEcCtD
Cisplatin—Dermatitis—Azathioprine—systemic scleroderma	0.00014	0.000731	CcSEcCtD
Cisplatin—SOD1—Hemostasis—SELP—systemic scleroderma	0.00014	0.00516	CbGpPWpGaD
Cisplatin—Flushing—Prednisone—systemic scleroderma	0.00014	0.000731	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—systemic scleroderma	0.000138	0.000721	CcSEcCtD
Cisplatin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000717	CcSEcCtD
Cisplatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000137	0.000715	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—systemic scleroderma	0.000137	0.000714	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000137	0.000712	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000712	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—systemic scleroderma	0.000136	0.000711	CcSEcCtD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000136	0.00499	CbGpPWpGaD
Cisplatin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000706	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—systemic scleroderma	0.000135	0.000703	CcSEcCtD
Cisplatin—Vomiting—Leflunomide—systemic scleroderma	0.000134	0.000697	CcSEcCtD
Cisplatin—Alopecia—Prednisone—systemic scleroderma	0.000133	0.000696	CcSEcCtD
Cisplatin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000133	0.000694	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000133	0.000693	CcSEcCtD
Cisplatin—Rash—Leflunomide—systemic scleroderma	0.000133	0.000691	CcSEcCtD
Cisplatin—Dermatitis—Leflunomide—systemic scleroderma	0.000132	0.00069	CcSEcCtD
Cisplatin—Nausea—Azathioprine—systemic scleroderma	0.000132	0.000689	CcSEcCtD
Cisplatin—Erythema—Prednisone—systemic scleroderma	0.000132	0.000685	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—systemic scleroderma	0.000132	0.000685	CcSEcCtD
Cisplatin—SOD1—Hemostasis—RHOB—systemic scleroderma	0.000131	0.00482	CbGpPWpGaD
Cisplatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00013	0.00068	CcSEcCtD
Cisplatin—Asthenia—Lisinopril—systemic scleroderma	0.00013	0.000676	CcSEcCtD
Cisplatin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000128	0.000665	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.000127	0.00469	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000127	0.00467	CbGpPWpGaD
Cisplatin—Rash—Mycophenolic acid—systemic scleroderma	0.000126	0.000659	CcSEcCtD
Cisplatin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000126	0.000659	CcSEcCtD
Cisplatin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000652	CcSEcCtD
Cisplatin—Nausea—Leflunomide—systemic scleroderma	0.000125	0.000651	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000125	0.00065	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—systemic scleroderma	0.000124	0.000646	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—systemic scleroderma	0.000124	0.000645	CcSEcCtD
Cisplatin—Diarrhoea—Lisinopril—systemic scleroderma	0.000124	0.000644	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000123	0.00451	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000122	0.000636	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—systemic scleroderma	0.000122	0.000634	CcSEcCtD
Cisplatin—Anaemia—Prednisone—systemic scleroderma	0.000122	0.000633	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000119	0.00439	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—CSK—systemic scleroderma	0.000119	0.00439	CbGpPWpGaD
Cisplatin—Nausea—Mycophenolic acid—systemic scleroderma	0.000119	0.000621	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000119	0.00438	CbGpPWpGaD
Cisplatin—Malaise—Prednisone—systemic scleroderma	0.000119	0.000618	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—systemic scleroderma	0.000118	0.000615	CcSEcCtD
Cisplatin—SOD1—Platelet degranulation—TGFB1—systemic scleroderma	0.000118	0.00434	CbGpPWpGaD
Cisplatin—Tinnitus—Methotrexate—systemic scleroderma	0.000118	0.000613	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000117	0.00432	CbGpPWpGaD
Cisplatin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000117	0.000611	CcSEcCtD
Cisplatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000608	CcSEcCtD
Cisplatin—Vomiting—Lisinopril—systemic scleroderma	0.000115	0.000599	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—systemic scleroderma	0.000114	0.000594	CcSEcCtD
Cisplatin—Rash—Lisinopril—systemic scleroderma	0.000114	0.000594	CcSEcCtD
Cisplatin—Convulsion—Prednisone—systemic scleroderma	0.000114	0.000594	CcSEcCtD
Cisplatin—Dermatitis—Lisinopril—systemic scleroderma	0.000114	0.000593	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000114	0.000593	CcSEcCtD
Cisplatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000592	CcSEcCtD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000112	0.00413	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—ITGAM—systemic scleroderma	0.000112	0.00413	CbGpPWpGaD
Cisplatin—Myalgia—Prednisone—systemic scleroderma	0.000112	0.000583	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—IL1A—systemic scleroderma	0.000112	0.00412	CbGpPWpGaD
Cisplatin—Anxiety—Prednisone—systemic scleroderma	0.000112	0.000581	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—systemic scleroderma	0.000112	0.000581	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000111	0.000579	CcSEcCtD
Cisplatin—Discomfort—Prednisone—systemic scleroderma	0.000111	0.000577	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—systemic scleroderma	0.00011	0.000573	CcSEcCtD
Cisplatin—Erythema—Methotrexate—systemic scleroderma	0.00011	0.000573	CcSEcCtD
Cisplatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000565	CcSEcCtD
Cisplatin—Nausea—Lisinopril—systemic scleroderma	0.000107	0.000559	CcSEcCtD
Cisplatin—Oedema—Prednisone—systemic scleroderma	0.000107	0.000559	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000107	0.000559	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000107	0.00394	CbGpPWpGaD
Cisplatin—Infection—Prednisone—systemic scleroderma	0.000107	0.000556	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—systemic scleroderma	0.000105	0.000549	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—systemic scleroderma	0.000105	0.000546	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—systemic scleroderma	0.000104	0.000543	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000104	0.000541	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—systemic scleroderma	0.000104	0.00054	CcSEcCtD
Cisplatin—Anorexia—Prednisone—systemic scleroderma	0.000102	0.000533	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000102	0.000531	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—systemic scleroderma	0.000102	0.000529	CcSEcCtD
Cisplatin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000525	CcSEcCtD
Cisplatin—Rash—Mycophenolate mofetil—systemic scleroderma	9.98e-05	0.00052	CcSEcCtD
Cisplatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.97e-05	0.00052	CcSEcCtD
Cisplatin—Malaise—Methotrexate—systemic scleroderma	9.91e-05	0.000517	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—systemic scleroderma	9.84e-05	0.000513	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.78e-05	0.00051	CcSEcCtD
Cisplatin—MT2A—Immune System—CSK—systemic scleroderma	9.77e-05	0.0036	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL1A—systemic scleroderma	9.76e-05	0.00359	CbGpPWpGaD
Cisplatin—Paraesthesia—Prednisone—systemic scleroderma	9.64e-05	0.000502	CcSEcCtD
Cisplatin—MT2A—Immune System—IRF5—systemic scleroderma	9.61e-05	0.00354	CbGpPWpGaD
Cisplatin—Convulsion—Methotrexate—systemic scleroderma	9.52e-05	0.000496	CcSEcCtD
Cisplatin—Nausea—Mycophenolate mofetil—systemic scleroderma	9.4e-05	0.00049	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL13—systemic scleroderma	9.38e-05	0.00345	CbGpPWpGaD
Cisplatin—Myalgia—Methotrexate—systemic scleroderma	9.36e-05	0.000488	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—systemic scleroderma	9.33e-05	0.000486	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.29e-05	0.000484	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—systemic scleroderma	9.24e-05	0.000482	CcSEcCtD
Cisplatin—MT2A—Immune System—IRF8—systemic scleroderma	9.18e-05	0.00338	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD247—systemic scleroderma	9.18e-05	0.00338	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ITGAM—systemic scleroderma	9.18e-05	0.00338	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Methotrexate—systemic scleroderma	8.97e-05	0.000467	CcSEcCtD
Cisplatin—Infection—Methotrexate—systemic scleroderma	8.91e-05	0.000464	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—systemic scleroderma	8.84e-05	0.000461	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—systemic scleroderma	8.8e-05	0.000458	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—systemic scleroderma	8.78e-05	0.000458	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—systemic scleroderma	8.71e-05	0.000454	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	8.69e-05	0.0032	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Methotrexate—systemic scleroderma	8.67e-05	0.000452	CcSEcCtD
Cisplatin—MT2A—Immune System—TNFAIP3—systemic scleroderma	8.6e-05	0.00317	CbGpPWpGaD
Cisplatin—Anorexia—Methotrexate—systemic scleroderma	8.55e-05	0.000446	CcSEcCtD
Cisplatin—MT2A—Immune System—BLK—systemic scleroderma	8.5e-05	0.00313	CbGpPWpGaD
Cisplatin—Body temperature increased—Prednisone—systemic scleroderma	8.48e-05	0.000442	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—systemic scleroderma	8.38e-05	0.000437	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	8.32e-05	0.00306	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.17e-05	0.000426	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—systemic scleroderma	8.05e-05	0.00042	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—systemic scleroderma	8e-05	0.000417	CcSEcCtD
Cisplatin—GSTT1—Metabolism—HSPG2—systemic scleroderma	7.97e-05	0.00294	CbGpPWpGaD
Cisplatin—Hypersensitivity—Prednisone—systemic scleroderma	7.91e-05	0.000412	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—systemic scleroderma	7.8e-05	0.000406	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.74e-05	0.000404	CcSEcCtD
Cisplatin—Asthenia—Prednisone—systemic scleroderma	7.7e-05	0.000401	CcSEcCtD
Cisplatin—Pain—Methotrexate—systemic scleroderma	7.67e-05	0.0004	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	7.54e-05	0.00278	CbGpPWpGaD
Cisplatin—GSTM1—NRF2 pathway—TGFB1—systemic scleroderma	7.47e-05	0.00275	CbGpPWpGaD
Cisplatin—Feeling abnormal—Methotrexate—systemic scleroderma	7.39e-05	0.000385	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—systemic scleroderma	7.34e-05	0.000383	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	7.13e-05	0.00262	CbGpPWpGaD
Cisplatin—Body temperature increased—Methotrexate—systemic scleroderma	7.09e-05	0.00037	CcSEcCtD
Cisplatin—MT2A—Immune System—CTLA4—systemic scleroderma	6.96e-05	0.00256	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	6.85e-05	0.00252	CbGpPWpGaD
Cisplatin—Vomiting—Prednisone—systemic scleroderma	6.82e-05	0.000356	CcSEcCtD
Cisplatin—Rash—Prednisone—systemic scleroderma	6.77e-05	0.000353	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—systemic scleroderma	6.76e-05	0.000352	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—systemic scleroderma	6.61e-05	0.000344	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—systemic scleroderma	6.44e-05	0.000335	CcSEcCtD
Cisplatin—Nausea—Prednisone—systemic scleroderma	6.37e-05	0.000332	CcSEcCtD
Cisplatin—GSTP1—NRF2 pathway—TGFB1—systemic scleroderma	6.35e-05	0.00234	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	6.21e-05	0.00229	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—TGFB1—systemic scleroderma	6.19e-05	0.00228	CbGpPWpGaD
Cisplatin—Diarrhoea—Methotrexate—systemic scleroderma	6.14e-05	0.00032	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.06e-05	0.00223	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CTGF—systemic scleroderma	6.04e-05	0.00222	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	6.04e-05	0.00222	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SMAD7—systemic scleroderma	5.99e-05	0.00221	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	5.9e-05	0.00217	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	5.87e-05	0.00216	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DQB1—systemic scleroderma	5.73e-05	0.00211	CbGpPWpGaD
Cisplatin—Vomiting—Methotrexate—systemic scleroderma	5.7e-05	0.000297	CcSEcCtD
Cisplatin—Rash—Methotrexate—systemic scleroderma	5.66e-05	0.000295	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—systemic scleroderma	5.65e-05	0.000294	CcSEcCtD
Cisplatin—SOD1—Hemostasis—MMP1—systemic scleroderma	5.62e-05	0.00207	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFBI—systemic scleroderma	5.48e-05	0.00202	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1A—systemic scleroderma	5.44e-05	0.002	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD40LG—systemic scleroderma	5.41e-05	0.00199	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.4e-05	0.00199	CbGpPWpGaD
Cisplatin—Nausea—Methotrexate—systemic scleroderma	5.33e-05	0.000278	CcSEcCtD
Cisplatin—ABCC5—NRF2 pathway—TGFB1—systemic scleroderma	5.32e-05	0.00196	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	5.25e-05	0.00193	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	5.23e-05	0.00192	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—HSPG2—systemic scleroderma	5.14e-05	0.00189	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.63e-05	0.0017	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—TGFB1—systemic scleroderma	4.62e-05	0.0017	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.59e-05	0.00169	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HSPG2—systemic scleroderma	4.37e-05	0.00161	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—HSPG2—systemic scleroderma	4.37e-05	0.00161	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—HSPG2—systemic scleroderma	4.26e-05	0.00157	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CSK—systemic scleroderma	4.22e-05	0.00155	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	4.15e-05	0.00153	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NOS3—systemic scleroderma	4.07e-05	0.0015	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.98e-05	0.00147	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD247—systemic scleroderma	3.97e-05	0.00146	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFB1—systemic scleroderma	3.93e-05	0.00145	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CTGF—systemic scleroderma	3.89e-05	0.00143	CbGpPWpGaD
Cisplatin—XDH—Metabolism—HSPG2—systemic scleroderma	3.82e-05	0.00141	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—HSPG2—systemic scleroderma	3.66e-05	0.00135	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.51e-05	0.00129	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CTGF—systemic scleroderma	3.31e-05	0.00122	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CTGF—systemic scleroderma	3.23e-05	0.00119	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.19e-05	0.00117	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—HSPG2—systemic scleroderma	3.17e-05	0.00117	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	3.15e-05	0.00116	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	3.11e-05	0.00115	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	3.08e-05	0.00113	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	2.97e-05	0.00109	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CTGF—systemic scleroderma	2.89e-05	0.00107	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—systemic scleroderma	2.84e-05	0.00105	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ACE—systemic scleroderma	2.84e-05	0.00104	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CTGF—systemic scleroderma	2.77e-05	0.00102	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HSPG2—systemic scleroderma	2.7e-05	0.000994	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—systemic scleroderma	2.69e-05	0.000992	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—NOS3—systemic scleroderma	2.63e-05	0.000968	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	2.45e-05	0.000901	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.42e-05	0.000889	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CTGF—systemic scleroderma	2.41e-05	0.000886	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	2.39e-05	0.000881	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMAD7—systemic scleroderma	2.32e-05	0.000855	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFBI—systemic scleroderma	2.12e-05	0.000782	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.11e-05	0.000777	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HSPG2—systemic scleroderma	2.06e-05	0.000759	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CTGF—systemic scleroderma	2.05e-05	0.000753	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HSPG2—systemic scleroderma	1.86e-05	0.000685	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HSPG2—systemic scleroderma	1.84e-05	0.000678	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP1—systemic scleroderma	1.82e-05	0.00067	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—NOS3—systemic scleroderma	1.69e-05	0.000624	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HSPG2—systemic scleroderma	1.69e-05	0.000624	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.66e-05	0.000613	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CSK—systemic scleroderma	1.64e-05	0.000603	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.6e-05	0.000589	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CTGF—systemic scleroderma	1.56e-05	0.000575	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD247—systemic scleroderma	1.54e-05	0.000567	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CCL2—systemic scleroderma	1.48e-05	0.000545	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS3—systemic scleroderma	1.44e-05	0.000531	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—NOS3—systemic scleroderma	1.44e-05	0.000531	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HSPG2—systemic scleroderma	1.42e-05	0.000523	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CTGF—systemic scleroderma	1.41e-05	0.000519	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—systemic scleroderma	1.41e-05	0.000519	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NOS3—systemic scleroderma	1.4e-05	0.000517	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CTGF—systemic scleroderma	1.4e-05	0.000514	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HSPG2—systemic scleroderma	1.36e-05	0.000502	CbGpPWpGaD
Cisplatin—XDH—Metabolism—NOS3—systemic scleroderma	1.26e-05	0.000464	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NOS3—systemic scleroderma	1.21e-05	0.000445	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.18e-05	0.000435	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CTGF—systemic scleroderma	1.08e-05	0.000396	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NOS3—systemic scleroderma	1.05e-05	0.000386	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CTGF—systemic scleroderma	1.03e-05	0.000381	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.01e-05	0.00037	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—systemic scleroderma	9.54e-06	0.000351	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSPG2—systemic scleroderma	9.4e-06	0.000346	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NOS3—systemic scleroderma	8.9e-06	0.000328	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CTGF—systemic scleroderma	7.63e-06	0.000281	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CTGF—systemic scleroderma	7.12e-06	0.000262	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—systemic scleroderma	6.8e-06	0.00025	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—systemic scleroderma	6.14e-06	0.000226	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—systemic scleroderma	6.08e-06	0.000224	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—systemic scleroderma	5.59e-06	0.000206	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—systemic scleroderma	4.68e-06	0.000172	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—systemic scleroderma	4.5e-06	0.000166	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—systemic scleroderma	3.7e-06	0.000136	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—systemic scleroderma	3.32e-06	0.000122	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.1e-06	0.000114	CbGpPWpGaD
